Michael Pfreundschuh, Deseased

Title: The Contributions of Michael Pfreundschuh in Cancer Research

Introduction

Michael Pfreundschuh was a notable inventor whose work significantly impacted cancer research. He was based in Homburg, Germany, and is remembered for his innovative contributions to the field. His dedication to advancing medical science is evident through his patent and collaborations with esteemed institutions.

Latest Patents

Michael Pfreundschuh held a patent titled "Methods and composition for a binding molecule targeting cancer cells expressing SSX2 peptide 41-49 in HLA-A*0201 context." This patent disclosed binding molecules related to Synovial Sarcoma X breakpoint 2 and outlined methods for their use in the detection and treatment of cancer. His work in this area has the potential to improve cancer diagnostics and therapies.

Career Highlights

Throughout his career, Pfreundschuh worked at prominent institutions, including Children's National Medical Center and Washington University. His experience in these organizations allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Michael Pfreundschuh collaborated with notable colleagues, including Eric Yvon and Catherine M. Bollard. These partnerships were instrumental in advancing his research and expanding the impact of his work in cancer treatment.

Conclusion

Michael Pfreundschuh's contributions to cancer research through his patent and collaborations have left a lasting legacy in the medical community. His innovative spirit and dedication to improving patient outcomes will be remembered.